Results 241 to 250 of about 456,413 (294)
Adjunctive GM-CSF therapy enhances host defense against systemic <i>Candida auris</i> infection in immunosuppressed mice. [PDF]
Mattos EC +5 more
europepmc +1 more source
Concurrent <i>Nocardia</i>, <i>Cryptococcus</i> and <i>Mycobacterium</i> Infections Unmask Anti-GM-CSF Antibody-Associated Immunodeficiency and Pulmonary Alveolar Proteinosis: A Case Report. [PDF]
Menon V.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
GM-CSF in Inflammation and Autoimmunity
Trends in Immunology, 2002Granulocyte macrophage-colony stimulating factor (GM-CSF) is now best viewed as a major regulator governing the functions of granulocyte and macrophage lineage populations at all stages of maturation. There is recent evidence for a key role for GM-CSF in inflammatory and autoimmune diseases, therefore making it worthy of consideration for targetting ...
John A. Hamilton
exaly +3 more sources
Loss of GM-CSF-Dependent Instruction of Alveolar Macrophages in COVID-19 Provides a Rationale for Inhaled GM-CSF Treatment [PDF]
GM-CSF promotes myelopoiesis and inflammation, and GM-CSF blockade is being evaluated as a treatment for COVID-19-associated hyperinflammation. Alveolar GM-CSF is, however, required for monocytes to differentiate into alveolar macrophages (AMs) that ...
Ingel K Demedts
exaly +2 more sources
The role of GM-CSF in infection
Infection, 1992GM-CSF is a hemopoietic growth factor with substantial effects on the proliferation of neutrophils, eosinophils and monocytes/macrophages. Its physiologic role in infection is still poorly understood. The gene for GM-CSF is constitutively transcribed in cells substantial for antiinfectious response. Various cells are activated and induced by TNF and IL-
M, Freund, H D, Kleine
openaire +2 more sources
Incidence of GM-CSF Antibodies in Cancer Patients Receiving GM-CSF for Immunostimulation
Clinical Immunology, 2001We have assessed the immunogenicity profile of GM-CSF in patients with either colorectal carcinoma (CRC) at different stages of disease or with multiple myeloma who were given recombinant human GM-CSF (Escherichia coli-derived) combination therapy. Metastatic CRC patients received a colon carcinoma-reactive antibody and high doses of GM-CSF (425--500 ...
G, Ullenhag +8 more
openaire +2 more sources
GM‐CSF and phorbol esters modulate GM‐CSF receptor expression by independent mechanisms
Journal of Cellular Physiology, 1991AbstractHuman granulocyte‐macrophage colony‐stimulating factor (GM‐CSF) (0.1 nM) down‐modulates its receptor in IL‐3/GM‐CSF dependent M‐07e cells, in KG‐1 cells and normal granulocytes, whereas phorbol esters 12‐O‐tetradecanoylphorbol‐13‐acetate (TPA) (2 nM) down‐modulates the GM‐CSF receptor in M‐07e cells and granulocytes but not in KG‐1 cells.
BRIZZI, Maria Felice +4 more
openaire +4 more sources
GM-CSF in marrow transplantation
European Journal of Cancer, 1993Bone marrow transplantation (BMT) is being increasingly used in a wide variety of diseases. During the period of re-engraftment the patient is particularly susceptible to a number of opportunistic infections which can radically affect acute morbidity and mortality.
openaire +2 more sources
Infection, 1992
Hematopoietic growth factors may mitigate the cytopenias that frequently complicate HIV disease or its treatment. Clinical and in vitro studies have indicated the ability of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) or erythropoietin (EPO) to overcome the myelosuppression of HIV or many of ...
openaire +2 more sources
Hematopoietic growth factors may mitigate the cytopenias that frequently complicate HIV disease or its treatment. Clinical and in vitro studies have indicated the ability of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) or erythropoietin (EPO) to overcome the myelosuppression of HIV or many of ...
openaire +2 more sources

